Like CSE1L, increased expression of PFDN4 was reported in various types of cancerous tumors, such as colorectal cancer [100,101], hepatocellular carcinoma [102], gastric cancer [103], breast cancer [104], or epithelial ovarian cancer [105]. Here, PFDN4 is linked to hepatocellular carcinoma.